Circulating MicroRNAs in blood of patients with prostate cancer

Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 5, 10.1016/j.cell.2004.12.035 Valladares-Ayerbes, 2012, Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer, J Transl Med, 10, 186, 10.1186/1479-5876-10-186 Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, 18, 997, 10.1038/cr.2008.282 Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci U S A, 105, 10513, 10.1073/pnas.0804549105 Brase, 2011, Circulating miRNAs are correlated with tumor progression in prostate cancer, Int J Cancer, 128, 608, 10.1002/ijc.25376 Selth, 2012, Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease, Int J Cancer, 131, 652, 10.1002/ijc.26405 Bryant, 2012, Changes in circulating microRNA levels associated with prostate cancer, Br J Cancer, 106, 768, 10.1038/bjc.2011.595 Pfaffl, 2002, Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR, Nucleic Acids Res, 30, e36, 10.1093/nar/30.9.e36 Kozomara, 2011, miRBase: integrating microRNA annotation and deep-sequencing data, Nucleic Acids Res, 39, D152, 10.1093/nar/gkq1027 Betel, 2008, The microRNA.org resource: targets and expression, Nucleic Acids Res, 36, D149 Yang, 2010, dbDEMC: a database of differentially expressed miRNAs in human cancers, BMC Genomics, 2, S5, 10.1186/1471-2164-11-S4-S5 Landgraf, 2007, A mammalian microRNA expression atlas based on small RNA library sequencing, Cell, 129, 1401, 10.1016/j.cell.2007.04.040 Zhang, 2007, GeneHub-GEPIS: digital expression profiling for normal and cancer tissues based on an integrated gene database, Nucleic Acids Res, 35, W152, 10.1093/nar/gkm381 Bargaje, 2010, Consensus miRNA expression profiles derived from interplatform normalization of microarray data, RNA, 16, 16, 10.1261/rna.1688110 Saeed, 2003, TM4: a free, open-source system for microarray data management and analysis, Biotecniques, 34, 374, 10.2144/03342mt01 Kral, 2011, Genetic determinants of prostate cancer: a review, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 155, 3, 10.5507/bp.155.2011.001 Tomlins, 2008, The role of SPINK1 in ETS rearrangement-negative prostate cancers, Cancer Cell, 13, 519, 10.1016/j.ccr.2008.04.016 Palanisamy, 2010, Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma, Nat Med, 16, 793, 10.1038/nm.2166 Taylor, 2010, Integrative genomic profiling of human prostate cancer, Cancer Cell, 18, 11, 10.1016/j.ccr.2010.05.026 Shen, 2010, Molecular genetics of prostate cancer: new prospects for old challenges, Genes Dev, 24, 1967, 10.1101/gad.1965810 Gandellini, 2009, Towards the definition of prostate cancer-related microRNAs: where are we now?, Trends Mol Med, 15, 381, 10.1016/j.molmed.2009.07.004 Schaefer, 2010, Suitable reference genes for relative quantification of miRNA expression in prostate cancer, Exp Mol Med, 42, 749, 10.3858/emm.2010.42.11.076 Sun, 2009, The role of microRNA 221 and microRNA-222 in androgen-independent prostate cancer cell lines, Cancer Res, 69, 3356, 10.1158/0008-5472.CAN-08-4112 Varambally, 2008, Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer, Science, 322, 1695, 10.1126/science.1165395 Pang, 2010, MicroRNAs and prostate cancer, Acta Biochim Biophys Sin (Shanghai), 42, 363, 10.1093/abbs/gmq038 Metias, 2009, MicroRNAs in clinical oncology: at the crossroads between promises and problems, J Clin Pathol, 62, 771, 10.1136/jcp.2009.064717 Weber, 2010, The microRNA spectrum in 12 body fluids, Clin Chem, 56, 1733, 10.1373/clinchem.2010.147405 Chen, 2012, A panel of five circulating MicroRNAs as potential biomarkers for prostate cancer, Prostate, 72, 1443, 10.1002/pros.22495